Lee Kaiser

685 total citations
12 papers, 479 citations indexed

About

Lee Kaiser is a scholar working on Psychiatry and Mental health, Pharmacology and Surgery. According to data from OpenAlex, Lee Kaiser has authored 12 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Psychiatry and Mental health, 5 papers in Pharmacology and 3 papers in Surgery. Recurrent topics in Lee Kaiser's work include Dementia and Cognitive Impairment Research (5 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Lee Kaiser is often cited by papers focused on Dementia and Cognitive Impairment Research (5 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Lee Kaiser collaborates with scholars based in United States, Germany and Canada. Lee Kaiser's co-authors include Florian Bieber, P. Murali Doraiswamy, John Lettieri, Allen H. Heller, Roger Echols, Mark Rogge, Barbara Gulanski, Jonathan Reuning‐Scherer, K. Ranga R. Krishnan and Jan M. Keppel Hesselink and has published in prestigious journals such as Neurology, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Lee Kaiser

12 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lee Kaiser United States 8 172 153 105 54 51 12 479
Giada Crescioli Italy 16 137 0.8× 123 0.8× 86 0.8× 26 0.5× 45 0.9× 65 770
Edward Whalen United States 8 385 2.2× 210 1.4× 113 1.1× 50 0.9× 73 1.4× 11 790
Qinying Zhao United States 17 165 1.0× 257 1.7× 278 2.6× 28 0.5× 74 1.5× 45 765
Irving H. Gomolin United States 15 66 0.4× 122 0.8× 132 1.3× 8 0.1× 32 0.6× 36 653
Menger Chung United States 17 194 1.1× 262 1.7× 63 0.6× 30 0.6× 3 0.1× 29 891
George Yü United States 7 61 0.4× 50 0.3× 117 1.1× 16 0.3× 15 0.3× 8 408
Silke Appel‐Dingemanse Switzerland 17 123 0.7× 253 1.7× 198 1.9× 11 0.2× 46 0.9× 30 990
Edward B. Kirsten United States 15 84 0.5× 81 0.5× 73 0.7× 14 0.3× 50 1.0× 25 790
Hayley J. Koslik United States 9 145 0.8× 40 0.3× 47 0.4× 20 0.4× 17 0.3× 13 346
L. O. Bor�us Sweden 16 88 0.5× 165 1.1× 90 0.9× 8 0.1× 19 0.4× 23 1000

Countries citing papers authored by Lee Kaiser

Since Specialization
Citations

This map shows the geographic impact of Lee Kaiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lee Kaiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lee Kaiser more than expected).

Fields of papers citing papers by Lee Kaiser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lee Kaiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lee Kaiser. The network helps show where Lee Kaiser may publish in the future.

Co-authorship network of co-authors of Lee Kaiser

This figure shows the co-authorship network connecting the top 25 collaborators of Lee Kaiser. A scholar is included among the top collaborators of Lee Kaiser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lee Kaiser. Lee Kaiser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
Doraiswamy, P. Murali & Lee Kaiser. (2000). Variability of the Mini-Mental State Examination in dementia. Neurology. 54(7). 1538–1539. 9 indexed citations
4.
Mazzu, Arthur, John Lettieri, Lee Kaiser, William S. Mullican, & Allen H. Heller. (1998). Influence of Age on the Safety, Tolerability, and Pharmacokinetics of the Novel HMG‐CoA Reductase Inhibitor Cerivastatin in Healthy Male Volunteers. The Journal of Clinical Pharmacology. 38(8). 715–719. 4 indexed citations
5.
Stahl, Stephen M., et al.. (1998). Effectiveness of ipsapirone, a 5-HT-1A partial agonist, in major depressive disorder: support for the role of 5-HT-1A receptors in the mechanism of action of serotonergic antidepressants. The International Journal of Neuropsychopharmacology. 1(1). 11–18. 27 indexed citations
6.
Doraiswamy, P. Murali, Florian Bieber, Lee Kaiser, et al.. (1997). The Alzheimer's disease assessment scale. Neurology. 48(6). 1511–1517. 122 indexed citations
7.
Doraiswamy, P. Murali, Florian Bieber, Lee Kaiser, et al.. (1997). Memory, language, and praxis in Alzheimer's disease: norms for outpatient clinical trial populations.. PubMed. 33(1). 123–8. 14 indexed citations
8.
Lettieri, John, et al.. (1997). 112 A multiple-dose study on the safety and pharmacokinetics of cerivastatin in young and elderly male volunteers. Atherosclerosis. 130. S29–S29. 7 indexed citations
9.
Morich, F, Florian Bieber, Lee Kaiser, et al.. (1996). Nimodipine in the Treatment of Probable Alzheimerʼs Disease. Clinical Drug Investigation. 11(4). 185–195. 45 indexed citations
10.
Lettieri, John, et al.. (1994). Comparative pharmacokinetics and safety of ciprofloxacin 400 mg iv thrice daily versus 750 mg po twice daily. Journal of Antimicrobial Chemotherapy. 33(4). 795–801. 32 indexed citations
11.
Lettieri, John, Lee Kaiser, G.J. Krol, & Allen H. Heller. (1993). Comparative Pharmacokinetics of Oral and Intravenous Ciprofloxacin. Drugs. 45(Supplement 3). 271–272. 1 indexed citations
12.
Lettieri, John, Mark Rogge, Lee Kaiser, Roger Echols, & Allen H. Heller. (1992). Pharmacokinetic profiles of ciprofloxacin after single intravenous and oral doses. Antimicrobial Agents and Chemotherapy. 36(5). 993–996. 124 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026